大動脈瘤市場：タイプ、製品、治療、最終用途別-2025-2030年の世界予測

大動脈瘤市場は、2023年に44億3,000万米ドルと評価され、2024年には47億9,000万米ドルに達すると予測され、CAGR 8.65％で成長し、2030年には79億2,000万米ドルに達すると予測されています。

大動脈瘤は、心臓から全身に血液を運ぶ主要動脈である大動脈の局所的な肥大です。大動脈の診断と治療の市場は、心血管疾患の有病率の上昇と、そのような疾患に罹患しやすくなった世界人口の高齢化によって牽引されています。さらに、高度な画像処理技術や血管内動脈瘤修復術（EVAR）などの外科手術が利用可能になりつつあることで、病院や専門クリニックの用途や最終用途の範囲が拡大しています。市場の成長は主に、診断ツールの技術的進歩、早期発見の重要性に関する啓発プログラム、政府の取り組みによって促進されています。しかし、治療に伴う高額な費用、恵まれない地域での限られたヘルスケアアクセス、熟練した医療専門家の必要性などが大きな課題となっています。主な成長機会としては、より費用対効果の高い診断ソリューションや低侵襲手術オプションの開発が挙げられ、これによって回復に要する時間やヘルスケアコストを削減しつつ、より幅広い層に対応できるようになります。イノベーションはバイオテクノロジーとデータ解析の交差点にあり、動脈瘤の形成と進行をより正確に予測するための遺伝子マーカーと人工知能に焦点を当てた調査が行われています。開発企業は、AIを活用した診断や個別化された治療計画を開発するため、ハイテク企業との提携を模索すべきです。しかし、コンプライアンスによって安全性と有効性の基準が保証されるため、複雑な規制を乗り越えることは極めて重要です。このようなハードルがあるにもかかわらず、市場はデジタルヘルスケアサービスの拡大から恩恵を受けることができ、大動脈瘤患者の遠隔モニタリングや診察を可能にすることで、いくつかのアクセス問題に対処することができます。結論として、大動脈瘤市場は高額な治療費や規制上の課題といった制約に直面しているが、AIやバイオテクノロジーにおける重点的な調査や戦略的提携によって、大きな進歩への道を開くことができます。このアプローチは、患者の予後改善を約束するだけでなく、心血管ヘルスケアにおけるイノベーションの最前線に企業を位置づけることになります。

市場力学：急速に進化する大動脈瘤市場の主要市場インサイトを公開

大動脈瘤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 高齢化社会における大動脈瘤の発生率の増加
  • リスク集団に対する啓発キャンペーンと定期的なスクリーニングの増加
• 市場抑制要因
  • 製品リコールの増加
• 市場機会
  • 医療画像技術および低侵襲手術技術の進歩
  • 医療機関同士の連携
• 市場の課題
  • 大動脈瘤の手術中および手術後の合併症に対する懸念

ポーターのファイブフォース：大動脈瘤市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：大動脈瘤市場における外部からの影響の把握

外部マクロ環境要因は、大動脈瘤市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析大動脈瘤市場における競合情勢の把握

大動脈瘤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス大動脈瘤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、大動脈瘤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨大動脈瘤市場における成功への道筋を描く

大動脈瘤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化社会における大動脈瘤の発生率増加
    • リスクのある人々に対する啓発キャンペーンと定期的な検査の増加
  • 抑制要因
    • 製品リコールの発生件数の増加
  • 機会
    • 医療画像技術と低侵襲手術技術の進歩
    • 医療機関間の連携
  • 課題
    • 大動脈瘤の手術中および手術後の合併症への懸念
• 市場セグメンテーション分析
  • タイプ：高血圧の高齢者に腹部の大動脈瘤（AAA）が増加
  • 最終用途：病院における重症大動脈瘤の管理と治療の進化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 大動脈瘤市場：タイプ別

• 腹部大動脈瘤
• 胸部大動脈瘤

第7章 大動脈瘤市場：製品別

• カテーテル
• ステントグラフト

第8章 大動脈瘤市場治療別

• 血管内動脈瘤修復
• 開腹手術による修復

第9章 大動脈瘤市場：最終用途別

• 外来手術センター
• クリニック
• 病院

第10章 南北アメリカの大動脈瘤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の大動脈瘤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの大動脈瘤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • カリフォルニア大学デービス校ヘルス、革新的で低侵襲性の大動脈デバイスを使用した地域初の臨床試験を開始
  • FDAが先進的治療のための新しいGoreデバイスを承認、TAMBE Endoprosthesisの排除装置を発表
  • Nectero Medical、革新的な大動脈瘤治療の重要な臨床試験を開始
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Altura Medical Inc.
• Artivion, Inc.
• Bentley InnoMed GmbH
• Bolton Medical, Inc.
• Boston Scientific Corporation
• Cardinal Health company
• Cook Medical Inc.
• CryoLife, Inc.
• Endologix Inc.
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Lemaitre Vascular Inc.
• LifeTech Scientific Corporation
• LivaNova PLC
• Lombard Medical, Inc.
• Medtronic PLC
• MicroPort Scientific Corporation
• Phenox GmbH
• Terumo Corporation
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. AORTIC ANEURYSM MARKET RESEARCH PROCESS
• FIGURE 2. AORTIC ANEURYSM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AORTIC ANEURYSM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AORTIC ANEURYSM MARKET DYNAMICS
• TABLE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR ANEURYSM REPAIR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 36. CANADA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. CHINA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. CHINA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CHINA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 58. CHINA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 59. INDIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. INDIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 62. INDIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 128. ITALY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ITALY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ITALY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 131. ITALY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 144. POLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. POLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. POLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 147. POLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 148. QATAR AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. QATAR AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. QATAR AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 151. QATAR AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 188. AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 189. AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

The Aortic Aneurysm Market was valued at USD 4.43 billion in 2023, expected to reach USD 4.79 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 7.92 billion by 2030.

An aortic aneurysm is a localized enlargement of the aorta, the main artery carrying blood from the heart to the rest of the body. The market for its diagnosis and treatment is driven by the rising prevalence of cardiovascular diseases and an aging global population more susceptible to such conditions. Additionally, the increasing availability of advanced imaging technologies and surgical procedures, such as endovascular aneurysm repair (EVAR), expands the application and end-use scope across hospitals and specialty clinics. Market growth is primarily fueled by technological advancements in diagnostic tools, awareness programs about the importance of early detection, and government initiatives. However, the high costs associated with treatment, limited healthcare access in underprivileged regions, and the need for skilled healthcare professionals pose significant challenges. Key growth opportunities include the development of more cost-effective diagnostic solutions and minimally invasive surgical options, which would cater to a broader demographic while reducing recovery time and healthcare costs. Innovation lies at the intersection of biotechnology and data analytics, with research focused on genetic markers and artificial intelligence to predict aneurysm formation and progression more accurately. Businesses should explore partnerships with tech companies to develop AI-powered diagnostics and personalized treatment plans. However, navigating regulatory complexities is crucial, as compliance ensures safety and efficacy standards. Despite these hurdles, the market can benefit from expanding digital healthcare services, enabling remote monitoring and consultation for aortic aneurysm patients, thereby addressing some access issues. In conclusion, while the aortic aneurysm market faces limitations like high treatment costs and regulatory challenges, focused research and strategic collaborations in AI and biotechnology can pave the way for significant advancements. This approach not only promises better patient outcomes but also positions companies at the forefront of innovation in cardiovascular healthcare.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aortic Aneurysm Market

The Aortic Aneurysm Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of aortic aneurysms among aging population
  • Rise in awareness campaigns and routine screenings for at-risk populations
• Market Restraints
  • Rising incidences of product recalls
• Market Opportunities
  • Advances in medical imaging technology and minimally invasive surgical techniques
  • Collaborations between medical institutions
• Market Challenges
  • Concerns over complications during and after surgery of aortic aneurysms

Porter's Five Forces: A Strategic Tool for Navigating the Aortic Aneurysm Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aortic Aneurysm Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aortic Aneurysm Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aortic Aneurysm Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aortic Aneurysm Market

A detailed market share analysis in the Aortic Aneurysm Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aortic Aneurysm Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aortic Aneurysm Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aortic Aneurysm Market

A strategic analysis of the Aortic Aneurysm Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aortic Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altura Medical Inc., Artivion, Inc., Bentley InnoMed GmbH, Bolton Medical, Inc., Boston Scientific Corporation, Cardinal Health company, Cook Medical Inc., CryoLife, Inc., Endologix Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lemaitre Vascular Inc., LifeTech Scientific Corporation, LivaNova PLC, Lombard Medical, Inc., Medtronic PLC, MicroPort Scientific Corporation, Phenox GmbH, Terumo Corporation, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Aortic Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm.
• Based on Product, market is studied across Catheters and Stent Grafts.
• Based on Treatment, market is studied across Endovascular Aneurysm Repair and Open Surgical Repair.
• Based on End-use, market is studied across Ambulatory Surgery Centers, Clinic, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of aortic aneurysms among aging population
    • 5.1.1.2. Rise in awareness campaigns and routine screenings for at-risk populations
  • 5.1.2. Restraints
    • 5.1.2.1. Rising incidences of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in medical imaging technology and minimally invasive surgical techniques
    • 5.1.3.2. Collaborations between medical institutions
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns over complications during and after surgery of aortic aneurysms
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing cases of abdominal aortic aneurysm (AAA) found in older individuals with high blood pressure
  • 5.2.2. End-use: Evolving management and treatment of severe cases of aortic aneurysms in the hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Aortic Aneurysm Market, by Type

• 6.1. Introduction
• 6.2. Abdominal Aortic Aneurysm
• 6.3. Thoracic Aortic Aneurysm

7. Aortic Aneurysm Market, by Product

• 7.1. Introduction
• 7.2. Catheters
• 7.3. Stent Grafts

8. Aortic Aneurysm Market, by Treatment

• 8.1. Introduction
• 8.2. Endovascular Aneurysm Repair
• 8.3. Open Surgical Repair

9. Aortic Aneurysm Market, by End-use

• 9.1. Introduction
• 9.2. Ambulatory Surgery Centers
• 9.3. Clinic
• 9.4. Hospitals

10. Americas Aortic Aneurysm Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Aortic Aneurysm Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Aortic Aneurysm Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. UC Davis Health Initiates Regional First in Clinical Trial Using Innovative, Less Invasive Aortic Device
  • 13.3.2. FDA Approves New Gore Device for Advanced Aortic Aneurysm Treatment, Introducing the Excluder TAMBE Endoprosthesis
  • 13.3.3. Nectero Medical Launches Pivotal Clinical Trial for Innovative Aortic Aneurysm Treatment
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Altura Medical Inc.
• 3. Artivion, Inc.
• 4. Bentley InnoMed GmbH
• 5. Bolton Medical, Inc.
• 6. Boston Scientific Corporation
• 7. Cardinal Health company
• 8. Cook Medical Inc.
• 9. CryoLife, Inc.
• 10. Endologix Inc.
• 11. Johnson & Johnson Services, Inc.
• 12. Koninklijke Philips N.V.
• 13. Lemaitre Vascular Inc.
• 14. LifeTech Scientific Corporation
• 15. LivaNova PLC
• 16. Lombard Medical, Inc.
• 17. Medtronic PLC
• 18. MicroPort Scientific Corporation
• 19. Phenox GmbH
• 20. Terumo Corporation
• 21. W. L. Gore & Associates, Inc.